Status not kept up to date
The 5th Generation Tele-Robotic-Assisted Percutaneous Coronary Intervention: A First-in-Human Trial
NCT06213714 · Yan'an Affiliated Hospital of Kunming Medical University · Updated 19 Jan 2024
- What is being tested
- 5G Tele-Robotic-Assisted PCI
- For
- Coronary Artery Disease; Myocardial Ischemia; Cardiovascular Diseases; Coronary Disease; Arteriosclerosis
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 12 people. The full rules are on the registry page.
- Where
- Not stated
- When
- Starts or started Feb 2024, ends Sept 2024. Registered 19 Jan 2024.
- Results
- None posted yet.
In the researchers' words
The objective of this study is to examine the safety and effectiveness, from both clinical and technical perspectives, of utilizing the 5G-Robotic VRS100 system in percutaneous coronary intervention (PCI).